TrialThe Journal of dermatology2017

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study.

Hideshi Torii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.